![IQWiG - Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen header](/_next/image?url=%2F_next%2Fstatic%2Fmedia%2Forga-header-cd.8fe85e02.webp&w=3840&q=75)
![IQWiG - Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen logo](/_next/image?url=https%3A%2F%2Fres.cloudinary.com%2Fbaito%2Fimage%2Fupload%2Fv1738024900%2Flogos%2Fd8y5nae4ss6fco9ttugp.png&w=3840&q=75)
IQWiG - Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
The
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
editThe Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) is a professionally independent, scientific institute that specializes in the evaluation of medical procedures and pharmaceuticals. It was established in 2004 as part of the GKV Modernization Act to improve the quality and efficiency of patient care in Germany[1][3].
Main Products and Services
edit- Evidence-Based Reports: The IQWiG produces reports on pharmaceuticals, non-drug treatment methods, diagnostic procedures, and disease management programs. These reports serve as the basis for decisions by the Federal Joint Committee (G-BA) regarding the reimbursement of services by statutory health insurance[1][3].
- Health Information: The IQWiG provides easily understandable health information for the public on the platform Gesundheitsinformation.de[1].
- Topic Check Medicine: Citizens can propose topics to be scientifically investigated. The results are published in Health Technology Assessment (HTA) reports[1].
Mission and Values
editThe main mission of the IQWiG is to improve the quality of patient care through evidence-based evaluations. It places great importance on independence and transparency in its scientific work[1][3].
Sustainability Goals and Initiatives
editThe IQWiG is involved in international projects for the further development of evidence-based medicine, particularly within the framework of EU programs. It supports the European benefit assessment of pharmaceuticals and advocates for maintaining transparency in these processes[5].
Current Developments
editCurrently, the IQWiG is participating in the introduction of a Europe-wide benefit assessment of new pharmaceuticals. It is also researching current medical topics such as antibiotic therapy and colorectal cancer screening[5].
Sources:
edit- 1 - https://flexikon.doccheck.com/de/IQWiG
- 2 - https://www.iqwig.de/methoden/allgemeine-methoden_entwurf-fuer-version-7.pdf
- 3 - https://de.wikipedia.org/wiki/Institut_f%C3%BCr_Qualit%C3%A4t_und_Wirtschaftlichkeit_im_Gesundheitswesen
- 4 - https://www.iqwig.de/methoden/allgemeine-methoden_entwurf-fuer-version-6-1.pdf
- 5 - https://www.g-ba.de/ueber-den-gba/arbeitsweise/sachverstaendige/